Yael L. Maxwell

The preliminary data open the door to an alternative approach to invasive monitoring in heart failure patients.

By targeting the TTR gene directly in the liver, the therapy “has opened up the door” to permanent treatment, says Sarah Cuddy.

Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.

Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.

COVID-19 “magnified” preexisting disparities for rural patients as compared with their urban counterparts, one study author says.

The latest version of the LLM had high concordance with a multidisciplinary heart team in choosing between PCI and CABG.

The change reflects a growing understanding of what resources are needed to offer these scans and will likely improve access.

Several experts argue that AI-QCA is not a replacement for OCT, but could be valuable in low-resource settings.

With the data under review by the FDA, experts estimate that a substantial population could potentially benefit.

(UPDATED) Specialty technologies are still needed for select patients, but balloons can do the job with “meticulous” planning and imaging.

The observational Welsh data show trainees perform slightly less risky cases, but adjusted in-hospital outcomes were similar.

Mental status should help inform the timing of PCI, given that less responsive patients fare worse, researchers say.

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

Asian Indian and Filipino populations seemed to need the most improvement with regard to treatment time and medical therapy.

New data highlight the importance of identifying sex-specific risk factors in CV care, experts say.

Results from BedMed and BedMed-Frail, as well as a meta-analysis, are consistent with what was seen in the TIME trial.

New French data are reassuring but emphasize the need for follow-up care in more severe cases, authors say.

The hope is that this multisocietal document reduces unnecessary presurgical testing and creates consistency, says John Doherty.

Retrospective data highlight the need for more sex-based risk-scores, planning, and research, one author says.

The agency estimates a $6 billion savings for itself and $1.5 for Medicare enrollees in out-of-pocket costs each year.